Diabetes Discharge Transitional CGM Study (DDT-CGM)

NAActive, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

July 1, 2024

Study Completion Date

December 1, 2024

Conditions
Diabetes Mellitus, Type 2
Interventions
DEVICE

CGM device with diabetic education, CGM education and a follow up protocol.

Blind CGM placed and recorded for 14 days after discharge and data downloaded

Trial Locations (1)

84321

Logan Regional Hospital, Logan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Intermountain Health Care, Inc.

OTHER

NCT04729985 - Diabetes Discharge Transitional CGM Study (DDT-CGM) | Biotech Hunter | Biotech Hunter